Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $230.0800 (0.97%) ($227.1500 - $230.0800) on Fri. Apr. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.76% (three month average) | RSI | 61 | Latest Price | $230.0800(0.97%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(50%) XLV(46%) SPLV(37%) DIA(36%) VYM(36%) | Factors Impacting UTHR price | UTHR will decline at least -0.88% in a week (0% probabilities). VIXM(-25%) VXX(-23%) UUP(-6%) SHY(-5%) TBT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.88% (StdDev 1.76%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $227.67(1.06%) | 10 Day Moving Average | $227.91(0.95%) | 20 Day Moving Average | $227.62(1.08%) | To recent high | -12.6% | To recent low | 7.8% | Market Cap | $10.206b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |